Novo-Nordisk A/S News

6-K: Financial Report for the Period 1 January 2024 to 30 September 2024

Nov 6 06:37 ET

6-K: Financial Report for the Period 1 January 2024 to 30 June 2024

Aug 7 06:56 ET

6-K: Novo Nordisk Stops the Ocedurenone CLARION-CKD Trial and Recognises Impairment Loss

Jun 26 13:22 ET

6-K: Financial Report for the Period 1 January 2024 to 31 March 2024

May 2 07:18 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 31 07:03 ET

Novo-Nordisk A/S | 20-F: FY2023 Annual Report

Jan 31 06:56 ET

Novo-Nordisk A/S | 6-K: Financial Report for the Period 1 January 2023 to 30 September 2023

Nov 2, 2023 07:27 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 16, 2023 06:00 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 10, 2023 06:27 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

May 4, 2023 06:58 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 13, 2023 08:17 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 1, 2023 08:03 ET

Novo-Nordisk A/S | 20-F: FY2022 Annual Report

Feb 1, 2023 07:53 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 2, 2022 06:33 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 3, 2022 11:13 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 29, 2022 07:00 ET

Novo-Nordisk A/S | 20-F: FY2021 Annual Report

Feb 2, 2022 09:06 ET

Novo-Nordisk A/S | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 2, 2022 06:05 ET

Novo-Nordisk A/S | 20-F: FY2020 Annual Report

Feb 3, 2021 14:34 ET

Novo-Nordisk A/S | 20-F: FY2019 Annual Report

Feb 5, 2020 09:36 ET